Biosimilars
The track is extensively spread over two days covering key aspects of Biosimilars: Innovation, Technology, Clinical Trials, Regulatory, Supply Chain, and Commercialization.
The track is extensively spread over two days covering key aspects of Biosimilars: Innovation, Technology, Clinical Trials, Regulatory, Supply Chain, and Commercialization.
The track has a holistic approach to Vaccines: Innovation, Technology, Clinical Trials, Regulatory, Supply Chain, and Commercialization spreading over two days.
The track will run for one day with an emphasis on CGT:Innovation, Technology, Clinical Trials, Regulatory, Supply Chain, and Commercialization.